Biogen Earnings miss, Revenue beats In Q4 By Investing.com

Biogen (NASDAQ:BIIB) reported on Wednesday fourth quarter earnings that missed analysts’ forecasts and revenue that topped expectations.

Biogen announced earnings per share of $4.58 on revenue of $2.85B. Analysts polled by Investing.com anticipated EPS of $4.75 on revenue of $2.8B.

Biogen shares are up 13% from the beginning of the year and are trading at $277.72 , down-from-52-week-high.They are outperforming the Nasdaq 100 which is up 4.41% from the start of the year.

Biogen follows other major Healthcare sector earnings this month

Biogen’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar